PixarBio Corp
CIK:0001623077|SEC Filings
Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
| Revenues {1} | ||||
| Revenues Earned | $ 14,995 | $ 21,472 | $ 56,514 | $ 75,455 |
| Operating Expenses | ||||
| Payroll Expense | 20,682 | 22,860 | 64,681 | 60,411 |
| General and administrative expenses | 40,819 | 24,803 | 130,014 | 90,184 |
| Total operating expenses | 61,501 | 47,663 | 194,695 | 150,595 |
| Net Loss | $ (46,506) | $ (26,191) | $ (138,181) | $ (75,140) |
| Net Loss Per Common Share - basic and diluted | $ 0.000 | $ (0.001) | $ 0.000 | $ (0.001) |
| Weighted average common shares outstanding- basic and diluted | 1,685,013,330 | 51,680,000 | 2,229,457,780 | 51,680,000 |
Consolidated Statements of Cash Flows - USD ($) |
9 Months Ended | |
|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $ (138,181) | $ (75,140) |
| Changes in operating assets and liabilities: | ||
| Depreciation | 6,572 | 0 |
| Accrued expenses | 1,842 | (15,592) |
| NET CASH USED IN OPERATING ACTIVITIES | (129,767) | (90,732) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Capital Contribution | 216,500 | 0 |
| Amounts received from related party | 104,000 | 90,000 |
| Amounts paid to related party (loan repayment) | (191,500) | 0 |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 129,000 | 90,000 |
| NET CHANGE IN CASH | (767) | (732) |
| Cash at beginning of period | 4,705 | 3,438 |
| Cash at end of period | 3,938 | 2,706 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: | ||
| Interest paid | 0 | 0 |
| Income tax paid | $ 0 | $ 0 |
Consolidated Balance Sheets - USD ($) |
Sep. 30, 2016 |
Dec. 31, 2015 |
|---|---|---|
| CURRENT ASSETS: | ||
| Cash | $ 3,938 | $ 4,705 |
| Total Current Assets | 3,938 | 4,705 |
| Total Fixed Assets | 149,011 | 155,583 |
| Goodwill | 209,000 | 209,000 |
| Total Assets | 361,949 | 369,288 |
| CURRENT LIABILITIES: | ||
| Accrued expenses | 5,414 | 3,572 |
| Advances from related party | 0 | 87,500 |
| Total Current Liabilities | 5,414 | 91,072 |
| STOCKHOLDERS' EQUITY: | ||
| Common stock at $0.0001 par value: 1,000,000,000 shares authorized; 51,680,000 shares issued and outstanding at Sept 30, 2016 and 2,501,680,000 shares outstanding at Dec 31, 2015 | 5,168 | 250,168 |
| Additional paid-in capital | 584,984 | 123,484 |
| Deficit accumulated | (233,617) | (95,436) |
| Total Stockholders' Equity | 356,535 | 278,216 |
| Total Liabilities and Stockholders' Equity | $ 361,949 | $ 369,288 |